全文获取类型
收费全文 | 116191篇 |
免费 | 7628篇 |
国内免费 | 2280篇 |
专业分类
耳鼻咽喉 | 1744篇 |
儿科学 | 1799篇 |
妇产科学 | 3021篇 |
基础医学 | 17086篇 |
口腔科学 | 2481篇 |
临床医学 | 11441篇 |
内科学 | 21530篇 |
皮肤病学 | 2877篇 |
神经病学 | 7719篇 |
特种医学 | 5342篇 |
外国民族医学 | 6篇 |
外科学 | 15511篇 |
综合类 | 4409篇 |
现状与发展 | 8篇 |
一般理论 | 27篇 |
预防医学 | 6101篇 |
眼科学 | 2610篇 |
药学 | 10022篇 |
21篇 | |
中国医学 | 2247篇 |
肿瘤学 | 10097篇 |
出版年
2023年 | 932篇 |
2022年 | 2571篇 |
2021年 | 4068篇 |
2020年 | 2237篇 |
2019年 | 2832篇 |
2018年 | 3570篇 |
2017年 | 2683篇 |
2016年 | 3171篇 |
2015年 | 4708篇 |
2014年 | 5714篇 |
2013年 | 6585篇 |
2012年 | 9726篇 |
2011年 | 9139篇 |
2010年 | 5525篇 |
2009年 | 4768篇 |
2008年 | 6700篇 |
2007年 | 6392篇 |
2006年 | 5836篇 |
2005年 | 5294篇 |
2004年 | 4701篇 |
2003年 | 4289篇 |
2002年 | 3696篇 |
2001年 | 3125篇 |
2000年 | 2807篇 |
1999年 | 2209篇 |
1998年 | 896篇 |
1997年 | 699篇 |
1996年 | 625篇 |
1995年 | 552篇 |
1994年 | 494篇 |
1993年 | 365篇 |
1992年 | 1036篇 |
1991年 | 894篇 |
1990年 | 813篇 |
1989年 | 739篇 |
1988年 | 671篇 |
1987年 | 670篇 |
1986年 | 532篇 |
1985年 | 459篇 |
1984年 | 349篇 |
1983年 | 303篇 |
1982年 | 169篇 |
1981年 | 180篇 |
1980年 | 140篇 |
1979年 | 284篇 |
1978年 | 230篇 |
1977年 | 142篇 |
1976年 | 154篇 |
1975年 | 152篇 |
1974年 | 160篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
While two prophylactic HPV vaccines have been proven notably efficacious in clinical trials, the effectiveness of these vaccines at the population level remains to be evaluated. To lay the foundation for understanding the strengths and limitations of different endpoints for future effectiveness research, we present a comprehensive review of HPV-related clinical outcomes, including: (i) HPV type-specific positivity and persistence, (ii) Pap diagnoses (ASC-US, LSIL, and HSIL), (iii) histologic cervical cancer precursor lesions (i.e., CIN1, CIN2, and CIN3), (iv) invasive cervical cancer (ICC), (v) anogenital warts, (vi) recurrent respiratory papillomatosis (RRP), and (vii) other HPV-associated cancers (vulvar, vaginal, anal, penile, and oropharyngeal). While research on the vaccines’ effects on these HPV clinical outcomes in the general population is presently limited, numerous large trials will soon be completed, making a priori discussion of these potential outcomes especially urgent. Furthermore, population level systems to track HPV-associated clinical outcomes may need to be developed for HPV vaccine effectiveness evaluation. 相似文献
82.
83.
Eun Hee Sohn Chang Joon Song Hyo-Jin Lee Samyong Kim Jae-Moon Kim Ae Young Lee 《JOURNAL OF CLINICAL NEUROLOGY》2007,3(2):108-111
Lymphomatoid granulomatosis (LG) is a potentially malignant lymphoproliferative disorder. The lung is the most common involved site, followed by the skin and nervous system. However, LG of the central nervous system presenting with Parkinsonism is very rare. We report a patient with LG who presented with parkinsonian features such as bilateral rigidity, bradykinesia, and agitation. Brain magnetic resonance imaging showed multifocal punctuate enhanced lesions in both supra- and infratentorial areas. Steroid pulse therapy resulted in a dramatical improvement in the symptoms and MRI abnormalities. 相似文献
84.
86.
Su Jin Park Su Jin Kim Yumie Rhee Ji Hyun Byun Seong Hwan Kim Myoung Hee Kim Eun Jig Lee Sung-Kil Lim 《Journal of bone and mineral research》2007,22(6):889-896
The FIGNL1 gene was proven to be a new subfamily member of ATPases associated with diverse cellular activities (AAA proteins). In this in vitro study, the AAA proteins inhibited osteoblast proliferation and stimulated osteoblast differentiation. We showed that FIGNL1 may play some regulatory role in osteoblastogenesis. INTRODUCTION: The fidgetin-like 1 (FIGNL1) gene encodes a new subfamily member of ATPases associated with diverse cellular activities (AAA proteins). Although the FIGNL1 protein localizes to both the nucleus and cytoplasm, the function of FIGNL1 remains unknown. In a previous study, we identified several genes that mediate the anabolic effects of basic fibroblast growth factor (bFGF) on bone by using microarray data. FIGNL1 was one of the genes that downregulated >2-fold in MC3T3-E1 cells after treatment with bFGF. Therefore, this study was aimed to identify and confirm the function of FIGNL1 on osteoblastogenesis. MATERIALS AND METHODS: We examined the effect of the FIGNL1 gene on proliferation, differentiation, and apoptosis in mouse osteoblast cells (MC3T3-E1 and mouse primary calvarial cells) using flow cytometry, RT-PCR, cell proliferation assay, and cell death assay. MC3T3-E1 cells and mouse calvarial cells were transfected with small interfering RNA (siRNA) directed against the FIGNL1 or nontargeting control siRNA and examined by cell proliferation and cell death assays. Also, FIGNL1 was fused to enhance green fluorescent protein (EGFP), and the EGFP-fused protein was transiently expressed in MC3T3-E1 cells. RESULTS: Reduced expression of FIGNL1 by bFGF and TGF-beta1 treatment was verified by RT-PCR analysis. Overexpression of FIGNL1 reduced the proliferation of MC3T3-E1 and calvarial cells, more than the mock transfected control cells did. In contrast, siFIGNL1 transfection significantly increased the proliferation of osteoblasts, whereas overexpression of FIGNL1 did not seem to alter apoptosis in osteoblasts. Meanwhile, overexpression of FIGNL1 enhanced the mRNA expression of alkaline phosphatase (ALP) and osteocalcin (OCN) in osteoblasts. In contrast, siFIGNL1 decreased the expression of ALP and OCN. A pEGFP-FIGNL1 transfected into MCT3-E1 cells had an initially ubiquitous distribution and rapidly translocated to the nucleus 1 h after bFGF treatment. CONCLUSIONS: From these results, we proposed that FIGNL1, a subfamily member of the AAA family of proteins, might play some regulatory role in osteoblast proliferation and differentiation. Further analyses of FIGNL1 will be needed to better delineate the mechanisms contributing to the inhibition of proliferation and stimulation of osteoblast differentiation. 相似文献
87.
88.
89.
Feng-Yuan Liu Chien-Yu Lin Joseph T Chang Shu-Hang Ng Shy-Chyi Chin Hung-Ming Wang Chun-Ta Liao Sheng-Chieh Chan Tzu-Chen Yen 《Journal of nuclear medicine》2007,48(10):1614-1619
Conventional work-up (CWU) with chest radiography, abdominal ultrasonography, and skeletal scintigraphy has limited value in M staging of nonkeratinizing nasopharyngeal carcinoma (NPC). Our aim was to evaluate whether (18)F-FDG PET could replace CWU by comparing their diagnostic efficacies. METHODS: Patients with histologically proven nonkeratinizing NPC and no prior treatment were prospectively enrolled. All study participants underwent CWU and (18)F-FDG PET for primary M staging. Distant metastasis was considered to be present if there was any reliable evidence identified within 1 y after diagnosis. The comparative diagnostic efficacies of (18)F-FDG PET, CWU, and the combination of (18)F-FDG PET and CWU (PET+CWU) were evaluated using the areas under the receiver-operating-characteristic (ROC) curves. RESULTS: Sixty-one (20.3%) of 300 eligible patients were found to have distant metastases. On a patient-based analysis, (18)F-FDG PET was found to be more effective than CWU (P < 0.001), whereas it was equally effective with PET+CWU (P = 0.130). On region-based analyses, (18)F-FDG PET was more effective than skeletal scintigraphy and chest radiography for detecting bone metastases (P < 0.001) and chest metastases (P < 0.001), respectively. (18)F-FDG PET and abdominal ultrasound were equally effective for detecting hepatic metastases (P = 0.127). On region-based analyses, the combination of (18)F-FDG PET and CWU did not yield any noticeable increase in diagnostic efficacy. CONCLUSION: (18)F-FDG PET can replace CWU in primary M staging of nonkeratinizing NPC. 相似文献
90.